Clinical Trial Update: Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating reward processing in major depressive disorder before and after desvenlafaxine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: Unity Health Toronto | Conditions: Depression, Anhedonia | Phase 4 | Status: COMPLETED